Sign in

CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company

Verastem, Inc.

Sign in to watch
Ticker
VSTM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
273269467
Phone
(781) 292-4200
Business address
117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market buy Director bought 5,000 shares at $7.31 ($36,550)
  3. 4 Open-market buy Executive VP & CCO bought 3,000 shares at $7.30 ($21,900)
  4. 4 Open-market buy Chief Operating Officer bought 3,000 shares at $7.00 ($21,000)
  5. 4 Open-market buy President and CEO bought 2,000 shares at $7.00 ($14,000)
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy Director bought 4,000 shares at $7.49 ($29,960)
  8. 4 Open-market buy Director bought 1,000 shares at an average $7.30 ($7,303)
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy President and CEO bought 10,500 shares at $7.00 ($73,500)
  11. 4 Open-market buy Chief Operating Officer bought 2,000 shares at an average $7.03 ($14,056)
  12. 4 Grant or award Chief Financial Officer acquired 50,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Executive VP & CCO bought 7,700 shares at $5.79 ($44,583)
  15. 4 Open-market buy Chief Strategy Officer bought 3,000 shares at $5.98 ($17,940)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 27 · 526 filings